Suppr超能文献

基于中国西部大规模前瞻性健康体检队列的严重 COVID-19 前血液学参数特征及轨迹:一项长达 13 年随访的纵向研究。

Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up.

机构信息

Department of Urology, Innovation Institute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Health Management Center, General Practice Medical Center, Innovation Institute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

出版信息

BMC Med. 2024 Mar 7;22(1):105. doi: 10.1186/s12916-024-03326-x.

Abstract

BACKGROUND

The relaxation of the "zero-COVID" policy on Dec. 7, 2022, in China posed a major public health threat recently. Complete blood count test was discovered to have complicated relationships with COVID-19 after the infection, while very few studies could track long-term monitoring of the health status and identify the characterization of hematological parameters prior to COVID-19.

METHODS

Based on a 13-year longitudinal prospective health checkup cohort of ~ 480,000 participants in West China Hospital, the largest medical center in western China, we documented 998 participants with a laboratory-confirmed diagnosis of COVID-19 during the 1 month after the policy. We performed a time-to-event analysis to explore the associations of severe COVID-19 patients diagnosed, with 34 different hematological parameters at the baseline level prior to COVID-19, including the whole and the subtypes of white and red blood cells.

RESULTS

A total of 998 participants with a positive SARS-CoV-2 test were documented in the cohort, 42 of which were severe cases. For white blood cell-related parameters, a higher level of basophil percentage (HR = 6.164, 95% CI = 2.066-18.393, P = 0.001) and monocyte percentage (HR = 1.283, 95% CI = 1.046-1.573, P = 0.017) were found associated with the severe COVID-19. For lymphocyte-related parameters, a lower level of lymphocyte count (HR = 0.571, 95% CI = 0.341-0.955, P = 0.033), and a higher CD4/CD8 ratio (HR = 2.473, 95% CI = 1.009-6.059, P = 0.048) were found related to the risk of severe COVID-19. We also observed that abnormality of red cell distribution width (RDW), mean corpuscular hemoglobin concentration (MCHC), and hemoglobin might also be involved in the development of severe COVID-19. The different trajectory patterns of RDW-SD and white blood cell count, including lymphocyte and neutrophil, prior to the infection were also discovered to have significant associations with the risk of severe COVID-19 (all P < 0.05).

CONCLUSIONS

Our findings might help decision-makers and clinicians to classify different risk groups of population due to outbreaks including COVID-19. They could not only optimize the allocation of medical resources, but also help them be more proactive instead of reactive to long COVID-19 or even other outbreaks in the future.

摘要

背景

2022 年 12 月 7 日,中国放宽了“零新冠”政策,这对最近的公共卫生构成了重大威胁。人们发现,在感染新冠病毒后,全血细胞计数检测与新冠病毒之间存在复杂的关系,但很少有研究能够对新冠病毒感染前的健康状况进行长期监测,并确定血液学参数的特征。

方法

本研究基于中国西部最大的医疗中心华西医院一项长达 13 年的纵向前瞻性健康检查队列,该队列约有 48 万名参与者。我们记录了政策实施后 1 个月内 998 名实验室确诊的新冠病毒感染者。我们进行了时间事件分析,以探索在新冠病毒感染前基线水平的 34 种不同血液学参数与严重新冠病毒患者诊断之间的关联,包括白细胞和红细胞的全血和亚型。

结果

该队列共记录了 998 名 SARS-CoV-2 检测阳性的参与者,其中 42 例为重症病例。对于与白细胞相关的参数,嗜碱性粒细胞百分比(HR=6.164,95%CI=2.066-18.393,P=0.001)和单核细胞百分比(HR=1.283,95%CI=1.046-1.573,P=0.017)较高与严重新冠病毒有关。对于与淋巴细胞相关的参数,淋巴细胞计数(HR=0.571,95%CI=0.341-0.955,P=0.033)较低,CD4/CD8 比值(HR=2.473,95%CI=1.009-6.059,P=0.048)较高与严重新冠病毒的风险相关。我们还观察到红细胞分布宽度(RDW)、平均红细胞血红蛋白浓度(MCHC)和血红蛋白的异常可能也与严重新冠病毒的发生有关。感染前 RDW-SD 和白细胞计数(包括淋巴细胞和中性粒细胞)的不同轨迹模式也与严重新冠病毒的风险显著相关(均 P<0.05)。

结论

我们的研究结果可能有助于决策者和临床医生对包括新冠病毒在内的疫情爆发进行人群风险分类。这不仅可以优化医疗资源的配置,还可以帮助他们在未来对长新冠病毒甚至其他疫情的爆发更积极主动,而不是被动应对。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be7/10921814/ddb13e54edfa/12916_2024_3326_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验